dc.contributor.author |
Shbaklo, Hadia |
|
dc.contributor.author |
Azar, Sami T. |
|
dc.contributor.author |
Terwedow, Henry |
|
dc.contributor.author |
Halaby, Georges |
|
dc.contributor.author |
Naja, Roy P. |
|
dc.contributor.author |
Zalloua, Pierre A. |
|
dc.date.accessioned |
2019-07-22T06:22:00Z |
|
dc.date.available |
2019-07-22T06:22:00Z |
|
dc.date.copyright |
2003 |
en_US |
dc.date.issued |
2019-07-22 |
|
dc.identifier.issn |
1879-1166 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10725/11109 |
|
dc.description.abstract |
Tumor necrosis factor alpha (TNF-α) is an important immunomodulator and is believed to be involved in the development or progression of type 1 diabetes. In the following study, we evaluated TNF-α promoter polymorphisms at positions −863 and −1031 and their association with type 1 diabetes in a group of 210 diabetic patients from Lebanon. Our results show that in our population, the C allele is predominant at position −863, whereas the A allele is very rare (2%). At position −1031, however, the C and T allele distribution was similar in both the patient (17.8% vs 82.2%, respectively) and the control (21.4% vs 79.6%) groups. No association of TNF-α genotype at position 1031 with type 1 diabetes was found as demonstrated by the family-based association test and the transmission disequilibrium test. However, when patient genotypes were compared, the recessive CC genotype was only found in type 1 diabetic males but not in type 1 diabetic females. This observation, however, requires further investigation in a larger sample before conclusive association to gender is suggested. In conclusion, our results demonstrate that no association between TNF-α polymorphism and type 1 diabetes seems to exist in our population. |
en_US |
dc.language.iso |
en |
en_US |
dc.title |
No association between the −1031 polymorphism in the TNF-α promoter region and type 1 diabetes |
en_US |
dc.type |
Article |
en_US |
dc.description.version |
Published |
en_US |
dc.author.school |
SOM |
en_US |
dc.author.idnumber |
20030001 |
en_US |
dc.author.department |
N/A |
en_US |
dc.description.embargo |
N/A |
en_US |
dc.relation.journal |
Human Immunology |
en_US |
dc.journal.volume |
64 |
en_US |
dc.journal.issue |
6 |
en_US |
dc.article.pages |
633-638 |
en_US |
dc.keywords |
Type 1 diabetes |
en_US |
dc.keywords |
Stumor necrosis factor-alpha |
en_US |
dc.keywords |
Polymorphism |
en_US |
dc.keywords |
HLA |
en_US |
dc.identifier.doi |
https://doi.org/10.1016/S0198-8859(03)00053-3 |
en_US |
dc.identifier.ctation |
Shbaklo, H., Azar, S. T., Terwedow, H., Halaby, G., Naja, R. P., & Zalloua, P. A. (2003). No association between the− 1031 polymorphism in the TNF-α promoter region and type 1 diabetes. Human immunology, 64(6), 633-638. |
en_US |
dc.author.email |
pierre.zalloua@lau.edu.lb |
en_US |
dc.identifier.tou |
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php |
en_US |
dc.identifier.url |
https://www.sciencedirect.com/science/article/pii/S0198885903000533 |
en_US |
dc.orcid.id |
https://orcid.org/0000-0002-8494-5081 |
en_US |
dc.author.affiliation |
Lebanese American University |
en_US |